Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3825307 Title: PROCÉDÉS DE SYNTHÈSE DE DEXTROMÉTHORPHANE DEUTÉRÉ

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
202037040
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3825307
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
03/07/2017
Grant date:
03/08/2022
EP publication date:
26/05/2021
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
03/08/2022
EP B1 publication date:
03/08/2022
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/07/2023
Expiration date (if granted and all annual fees paid):
03/07/2037

Applicant

Name:
Avanir Pharmaceuticals, Inc.
Legal Form:
From:
03/08/2022
Address:
30 Enterprise, Suite 200, Aliso Viejo, CA 92656, United States (US)
To:

Inventor

1

Name:
JOHNSON, Matt
Legal Form:
Address:
Morrisville, North Carolina 27560, United States (US)

2

Name:
ZHAO, Cunxiang
Legal Form:
Address:
Tianjin, 300457, China (CN)

3

Name:
MENG, Weihua
Legal Form:
Address:
Tianjin, 300457, China (CN)

4

Name:
LU, Zhijun
Legal Form:
Address:
Tianjin, 300457, China (CN)

5

Name:
LI, Yan
Legal Form:
Address:
Tianjin, 300457, China (CN)

Priority

Priority patent number:
PCT/CN2016/088414
Priority date:
04/07/2016
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
C07D 221/28; A61P 11/14;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2022/15
Publication date:
26/09/2022
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2024/05
Publication date:
19/03/2024
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
202231
Publication date:
03/08/2022
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type